Nucleic acid delivery with chitosan hydroxybenzotriazole

Oligonucleotides

Volumn 20, Issue 3, 2010, Pages 127-136

  Opanasopit, Praneet ^a   Techaarpornkul, Sunee ^a   Rojanarata, Theerasak ^a   Ngawhirunpat, Tanasait ^a   Ruktanonchai, Uracha ^b  

^a SILPAKORN UNIVERSITY   (Thailand)

^b NATIONAL SCIENCE AND TECHNOLOGY DEVELOPMENT AGENCY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CHITOSAN; DNA; ENHANCED GREEN FLUORESCENT PROTEIN; HYDROXYBENZOTRIAZOLE; ORGANIC COMPOUND; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; DRUG CARRIER; NUCLEIC ACID;

AGAR GEL ELECTROPHORESIS; ARTICLE; CELL VIABILITY; COMPLEX FORMATION; CYTOTOXICITY TEST; DNA DRUG COMPLEX; DNA PROTEIN COMPLEX; DRUG DELIVERY SYSTEM; DRUG DNA BINDING; GENE EXPRESSION REGULATION; GENE SILENCING; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MOLECULAR WEIGHT; PARTICLE SIZE; PRIORITY JOURNAL; RNA BINDING; ZETA POTENTIAL; CELL LINE; CHEMISTRY; PLASMID;

CELL LINE; CHITOSAN; DRUG CARRIERS; HUMANS; NUCLEIC ACIDS; PLASMIDS; RNA, SMALL INTERFERING;

EID: 77954134610     PISSN: 15454576     EISSN: None     Source Type: Journal    
DOI: 10.1089/oli.2009.0227     Document Type: Article

References (31)

1. C̃́ARRENO-GOMEZ, B., and DUNCAN, R. (1997). Evaluation of the biological properties of soluble chitosan and chitosan mi-crosphere. Int. J. Pharm. 148, 231-240.
2. DANG, J.M., and LEONG, K.W. (2006). Natural polymers for gene delivery and tissue engineering. Adv. Drug Deliv. Rev. 58, 487-499.
3. DORSETT, Y., and TUSCHL, T. (2004). siRNAs: applications in functional genomics and potential as therapeutics. Nat. Rev. Drug Discov. 3, 318-329.
4. FANGKANGWANWONG, J., AKASHI, M., KIDA, T., and CHIRACHANCHAI, S. (2006). Chitosan-hydroxybenzotriazole aqueous solution: a novel water-based system for chitosan functionalization. Macrom. Rapid Comm. 27, 1039-1046.
5. GRAYSON, A.C., DOODY, A.M., and PUTNAM, D. (2006). Biophysical and structural characterization of poly-ethylenimine-mediated siRNA delivery in vitro. Pharm. Res. 23, 1868-1876.
6. HOWARD, K.A., RAHBEK, U.L., LIU, X., DAMGAARD, C.K., GLUD, S.Z., ANDERSEN, M.O., HOVGAARD, M.B., SCHMITZ, A., NYENGAARD, J.R., BESENBACHER, F., and KJEMS, J. (2006). RNA interference in vitro and in vivo using a novel chitosan=siRNA nanoparticle system. Mol. Ther. 14, 476-484.
7. HUANG, M., FONG, C.W., KHORC, E., and LIM, L.Y. (2005). Transfection efficiency of chitosan vectors: effect of polymer molecular weight and degree of deacetylation. J. Control. Release 106, 391-406.
8. ISHII, T., OKAHATA, Y., and SATO, T. (2001). Mechanism of cell transfection with plasmid=chitosan complexes. Biochim. Biophys. Acta 1514, 51-64.
9. JERE, D., JIANG, H.L., AROTE, R., KIM, Y.K., CHOI, Y.J., CHO, M.H., AKAIKE, T., and CHO, C.S. (2009). Degradable poly-ethylenimines as DNA and small interfering RNA carriers. Expert Opin. Drug Deliv. 6, 827-834.
10. KATAS, H., and ALPAR, H.O. (2006). Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release 115, 216-225.
11. KIANG, T., WEN, J., LIM, H.W., and LEONG, K.W. (2004). The effect of the degree of chitosan deacetylation on the efficiency of gene transfection. Biomaterials 25, 5293-5301.
12. LANDEN, C.N., Jr., CHAVEZ-REYES, A., BUCANA, C., SCHMANDT, R., DEAVERS, M.T., LOPEZ-BERESTEIN, G., and SOOD, A.K. (2005). Therapeutic EphA2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65, 6910-6918.
13. ĹAVERTU, M., METHOT, S., TRAN-KHANH, N., and BUSCHMANN, M.D. (2006). High efficiency gene transfer using chitosan=DNA nanoparticles with specific combinations of molecular weight and degree of deacetylation. Biomaterials 27, 4815-4824.
14. LEE, M., NAH, J.W., KWON, Y., KOH, J.J., KO, K.S., and KIM, S.W. (2001). Water-soluble and low molecular weight chitosan-based plasmid DNA delivery. Pharm. Res. 18, 427-431.
15. LIU, X., HOWARD, K.A., DONG, M., ANDERSEN, M.O., RAHBEK, U.L., JOHNSEN, M.G., HANSEN, O.C., BE-SENBACHER, F., and KJEMS, J. (2007). The influence of polymeric properties on chitosan=siRNA nanoparticle formulation and gene silencing. Biomaterials 28, 1280-1288.
16. LUNDSTROM, K. (2003). Latest development in viral vectors for gene therapy. Trends Biotechnol. 21, 117-122. (Pubitemid 36293768)
17. MacLAUGHLIN, F.C., MUMPER, R.J., WANG, J., TAGLIA-FERRI, J.M., GILL, I., HINCHYIFFE, M., and ROLLAND, A.P. (1998). Chitosan and depolymerized chitosan oligomers as condensing carriers for in vivo plasmid delivery. J. Control. Release 56, 259-272.
18. MAO, S., SUN, W., and KISSEL, T. (2010). Chitosan-based formulations for delivery of DNA and siRNA. Adv. Drug Deliv. Rev. 62, 12-27.
19. MIDOUX, P., BREUZARD, G., GOMEZ, J.P., and PICHON, C. (2008). Polymer-based gene delivery: a current review on the uptake and intracellular trafficking of polyplexes. Curr. Gene Ther. 8, 335-352.
20. M̀IDOUX, P., PICHON, C., YAOUANC, J.J., and JAFFRES, P.A. (2009). Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br. J. Pharmacol. 157, 166-178.
21. PILLE, J.Y., LI, H., BLOT, E., BERTRAND, J.R., PRITCHARD, L.L., OPOLON, P., MAKSIMENKO, A., LU, H., VANNIER, J.P., SORIA, J., MALVY, C., and SORIA, C. (2006). Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: safety and efficacy in xenografted aggressive breast cancer. Hum. Gene Ther. 17, 1019-1026.
22. ROJANARATA, T., OPANASOPIT, P., TECHAARPORNKUL, S., NGAWHIRUNPAT, T., and RUKTANONCHAI, U. (2008). Chitosan-thiamine pyrophosphate as a novel carrier for siR-NA delivery. Pharm. Res. 25, 2807-2814.
23. RYTHER, R.C., FLYNT, A.S., PHILLIPS, J.A., and PATTON, J.G. (2005). siRNA therapeutics: big potential from small RNAs. Gene Ther. 1, 25-111
24. SATO, T., ISHII, T., and OKAHATA, Y. (2001). In vitro gene delivery mediated by chitosan: effect of pH, serum, and molecular mass of chitosan on the transfection efficiency. Biomaterials 22, 2075-2080.
25. SHARP, P.A. (2001). RNA interference. Genes Dev. 15, 485-490.
26. TANG, R., PALUMBO, R.N., NAGARAJAN, L., KROGSTAD, E., and WANG, C. (2010). Well-defined block copolymers for gene delivery to dendritic cells: probing the effect of polyca-tion chain-length. J. Control. Release 142, 229-237.
27. URBAN-KLEIN, B., WERTH, S., ABUHARBEID, S., CZUBAY-KO, F., and AIGNER, A. (2005). RNAi-mediated gene-targeting through systemic application of polyethylenimine (PEI)-complexed siRNA in vivo. Gene Ther. 12, 461-466.
28. WEECHARANGSAN, W., OPANASOPIT, P., NGAWHIR-UNPAT, T., APIRAKARAMWONG, A., ROJANARATA, T., RWKTANONCHAI, U., and LEE, R.J. (2008). Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells. Int. J. Pharm. 348, 161-168.
29. WEECHARANGSAN, W., OPANASOPIT, P., NGAWHIRUN-PAT, T., ROJANARATA, T., and APIRAKARAMWONG, A. (2006). Chitosan lactate as a nonviral gene delivery vector in COS-1 cells. AAPS PharmSciTech. 7, E1-E6.
30. YANG, C., WANG, X., LI, H., TAN, E., LIM, C.T., and LI, J. (2009). Cationic polyrotaxanes as gene carriers: physico-chemical properties and real-time observation of DNA com-plexation, and gene transfection in cancer cells. J. Phys. Chem. B 113, 7903-7911.
31. ZHAO, X., YU, S.B., WU, F.L., MAO, Z.B., and YU, C.L. (2006). Transfection of primary chondrocytes using chitosan-pEGFP nanoparticles. J. Control. Release 112, 223-228.